Biofrontera AG Stock
€2.72
Your prediction
Financial data and news for Biofrontera
sharewise wants to provide you with the best news and tools for Biofrontera, so we directly link to the best financial data sources.
Financials
News

Biofrontera Q2 Revenue Jumps 15%
Biofrontera(NASDAQ:BFRI) reported fiscal second quarter results for the period ended June 30, 2025, with total revenues rising to $9 million from $7.8 million a year earlier, representing a 15%

Biofrontera Revenue Jumps 15% in Q2
Biofrontera (NASDAQ:BFRI), a specialty biopharmaceutical company focused on dermatology solutions, released its financial results for the second quarter of fiscal 2025 on August 13, 2025. The